Author

Federico Argüelles

CLINICAL DIFFERENTIAL CHARACTERISTICS OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) OF ONSET IN PEDIATRIC AGE COMPARED TO PATIENTS DIAGNOSED IN ADULTHOOD

Maria Chaparro Sanchez, Ana Garre, Elena Ricart, Valle García-Sánchez, Carlos Taxonera, Miriam Mañosa, Isabel Vera Mendoza, Miguel Mínguez, Federico Argüelles, Luisa de Castro, M Arroyo, Antonio López-Sanromán, Montserrat Rivero Tirado, Jordi Guardiola Capon, María Dolores Martín-Arranz, Belen Beltran, Jesús Barrio, Sabino

EFFECTIVENESS AND SAFETY OF THE SWITCH FROM REMICADE<sup>®</sup> TO CT-P13 IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Maria Chaparro Sanchez, A Garre, Maria Fernanda Guerra Veloz, J M Vázquez, M L De Castro, Eduardo Leo Carnerero, E Rodríguez, A Y Carbajo, Sabino Riestra Menéndez, I Jiménez, Xavier Calvet Calvo, Luis Bujanda, Montserrat Rivero, Fernando Gomollón, Jose Manuel Benitez, Fernando Bermejo, Noelia Alcaide, Ana Gutierrez Casbas;

EVOLUTION AFTER ANTI-TNF DRUG DISCONTINUATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD): A MULTICENTER LONG-TERM FOLLOW-UP STUDY

María José Casanova González, Maria Chaparro Sanchez, V. García-Sánchez, O Nantes, E. Leo, Maria Rojas-Feria, Aranzazu Jauregui Amezaga, S García-López, J. M. Huguet, Joan Tosca, M P Martinez-Montiel, Federico Argüelles, M Aicart, I Marín, M Gómez-García, F Muñoz, M Esteve, L Bujanda, X Cortés, Juan Ramón Pineda, E Domè

Is the switch to a second thiopurine a safe strategy in elderly patients with inflammatory bowel disease? A multicentre cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Sandra Marín Pedrosa, Marta Calvo, Francisco Rodriguez-Moranta, Carlos Taxonera Samso, Pilar Nos Mateu, Francisco Mesonero, Mariló Martin-Arranz, Miguel Mínguez, Javier Gisbert, Santiago López, Ruth De Francisco Garcia, Fernando Gomollón Garcia, Xavier Calvet, Esther Garc

LONG-TERM OUTCOMES OF ENTEROCUTANEOUS FISTULA COMPLICATING CROHN’S DISEASE: ECUFIT STUDY FROM GETECCU

Milagros Vela Gonzalez, Berta Caballol Oliva, Cristina García, Pilar Soto, Eugenia Sanchez Rodriguez, Marta Isabel Calvo Moya, Iago Rodríguez-Lago, Margalida Calafat Sard, Francisco Javier Garcia-Alonso, Alejandra Utrilla, Rocío Ferreiro-Iglesias, Carlos González-Muñoza, Beatriz Sicilia, Erika Alfambra, Pedro Almela, Federic

Risk of immunomediated adverse events or secondary loss of response to infliximab in elderly patients with inflammatory bowel disease. A cohort study of the ENEIDA registry

Margalida Calafat Sard, Miriam Mañosa, Elena Ricart, Pilar Nos Mateu, Eva Iglesias, Isabel Vera, Antonio López-San Román, Jordi Guardiola, Carlos Taxonera, Miguel Mínguez, Mariló Martin-Arranz, Luisa de Castro, Sabino Riestra, Montserrat Rivero, Esther García-Planella, Xavier Calvet, Santiago López, Montserrat Andreu, Fer

Item 1 - 6 / 6
1